Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial
Clinical trial NCT03735446 · TERMINATED
Trial details
- NCT number
- NCT03735446
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-18
- Primary completion
- 2019-03-29
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.